Raclopride studies of dopamine release: dependence on presynaptic integrity (Q44672170)

5 December 2017

title

Raclopride studies of dopamine release: dependence on presynaptic integrity (English)

1 reference

5 December 2017

0 references

Doris J Doudet

1 reference

5 December 2017

James E Holden

series ordinal

1 reference

5 December 2017

language of work or name

English

0 references

publication date

1 December 2003

1 reference

5 December 2017

published in

Biological Psychiatry

1 reference

5 December 2017

1 reference

5 December 2017

1 reference

5 December 2017

page(s)

1193-1199

1 reference

Schizophrenia is associated with elevated amphetamine-induced synaptic dopamine concentrations: evidence from a novel positron emission tomography method

5 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900288-9

Amphetamine-induced dopamine release in the rat striatum: an in vivo microdialysis study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900288-9

In vivo [3H]spiperone binding: evidence for accumulation in corpus striatum by agonist-mediated receptor internalization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900288-9

Striatal binding of the PET ligand 11C-raclopride is altered by drugs that modify synaptic dopamine levels

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900288-9

6-[18F]Fluoro-L-DOPA PET studies of the turnover of dopamine in MPTP-induced parkinsonism in monkeys

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900288-9

In vivo PET studies of the dopamine D2 receptors in rhesus monkeys with long-term MPTP-induced parkinsonism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900288-9

Density and affinity of the dopamine D2 receptors in aged symptomatic and asymptomatic MPTP-treated monkeys: PET studies with [11C]raclopride

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900288-9

Kinetic Modeling of [11C]Raclopride: Combined PET-Microdialysis Studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900288-9

Quantitative analysis of D2 dopamine receptor binding in the living human brain by PET.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900288-9

Changes in striatal D2-receptor density following chronic treatment with amphetamine as assessed with PET in nonhuman primates

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900288-9

Comparison of the in vitro receptor binding properties of N-[3H]methylspiperone and [3H]raclopride to rat and human brain membranes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900288-9

In vivo receptor assay with multiple ligand concentrations: an equilibrium approach

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900288-9

Mechanisms of amphetamine action revealed in mice lacking the dopamine transporter

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900288-9

Evidence for striatal dopamine release during a video game

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900288-9

Concomitant characterization of behavioral and striatal neurotransmitter response to amphetamine using in vivo microdialysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900288-9

Imaging synaptic neurotransmission with in vivo binding competition techniques: a critical review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900288-9

The role of endogenous sensitization in the pathophysiology of schizophrenia: implications from recent brain imaging studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900288-9

Single photon emission computerized tomography imaging of amphetamine-induced dopamine release in drug-free schizophrenic subjects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900288-9

Microdialysis and SPECT measurements of amphetamine-induced dopamine release in nonhuman primates

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900288-9

Distribution volume ratios without blood sampling from graphical analysis of PET data

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900288-9

THE ATTRACTIONS OF PROTEINS FOR SMALL MOLECULES AND IONS

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900288-9

Pseudo non-competitive agonist interactions with dopamine receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900288-9

Levodopa-induced changes in synaptic dopamine in patients with Parkinson's disease as measured by [11C]raclopride displacement and PET.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900288-9

Isoflurane anesthesia enhances the inhibitory effects of cocaine and GBR12909 on dopamine transporter: PET studies in combination with microdialysis in the monkey brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900288-9

Is synaptic dopamine concentration the exclusive factor which alters the in vivo binding of [11C]raclopride?: PET studies combined with microdialysis in conscious monkeys

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900288-9

10.1016/S0006-3223(03)00288-9

7 January 2021

Identifiers

DOI

1 reference

5 December 2017

1 reference